MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Estrogen and related hormone effects
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,795 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,795 works in the cohort · of 4,299,418page 28 of 36

Labels cover 7 of 1,795 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,795 of 1,795 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

aboutno affunlabeled
Menopause Mouse
Mary Beckman
2002· article· en· Science of Aging Knowledge Environment· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affno abstractunlabeled
(652)
M. Spooner, Isabelle Gaumond, P. Robichaud, Joanne Carrier, S. Marchand
2006· article· en· Journal of Pain· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · insufficient_payloadconsensus · none
2
citations
affunlabeled
Update on the use of letrozole in breast cancer
Melinda Wu, Paul E. Goss
2007· review· en· Expert Opinion on Pharmacotherapy· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Prostate Cancer, Gonadal Hormones, and My Brain
Richard J. Wassersug
2014· letter· en· Journal of Sex & Marital Therapy· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
OR11-02 Structural Determinants of Pure Antiestrogenic Activity
Amandine Vallet, Marine Diennet, Khady Thiombane, Anaïs J I Vivet, Sandra Weber, Mohamed El Ezzy +8 more
2023· article· en· Journal of the Endocrine Society· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
1
citations
affunlabeled
Patient-reported outcomes from MA.17R: A randomized trial of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.
Julie Lemieux, Paul E. Goss, Wendy R. Parulekar, James N. Ingle, Kathleen I. Pritchard, Nicholas J. Robert +7 more
2016· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
1
citations
affno abstractunlabeled
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)
Hanna Bandos, Priya Rastogi, Samuel A. Jacobs, André Robidoux, Louis Fehrenbacher, Patrick J. Ward +11 more
2022· erratum· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
1
citations
affno abstractunlabeled
Steroid-Peptide Conjugates
Witold Neugebauer, Jérôme Côté, Audrey Fortier, Ghassan Bkaily, Levon Avedanian, Danielle Jaques +1 more
2006· book-chapter· en· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogenhormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest forthe ideal oestrogen therapy
Jonathan Douxfils, Jean‐Michel Foidart, Ulysse Gaspard, Guillaume Chatel, Mélanie Taziaux, Maud Jost +2 more
2023· article· en· Menopausal Review· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
1
citations

How this was built: Screen · Findings · About